Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2022 Apr 20;17(4):e0267628.
doi: 10.1371/journal.pone.0267628. eCollection 2022.

Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

Michela Garofalo, Young-Jun Jeon, Gerard J Nuovo, Justin Middleton, Paola Secchiero, Pooja Joshi, Hansjuerg Alder, Natalya Nazaryan, Gianpiero Di Leva, Giulia Romano, Melissa Crawford, Patrick Nana-Sinkam, Carlo M Croce
Published Erratum

Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

Michela Garofalo et al. PLoS One. .

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0067581.].

PubMed Disclaimer

Erratum for

Similar articles

See all similar articles

Cited by

References

    1. Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, et al.. (2013) MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. PLOS ONE 8(6): e67581. 10.1371/journal.pone.0067581 - DOI - PMC - PubMed
    1. Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, et al.. (2015) Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. PLOS ONE 10(6): e0131729. 10.1371/journal.pone.0131729 - DOI - PMC - PubMed
    1. Gallardo E, Navarro A, Viñolas N, Marrades RM, Diaz T, Gel B et al.. (2009) miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 30(11): 903–1909. doi: 10.1093/carcin/bgp219 - DOI - PubMed
    1. Bauman JE, Eaton KD and Martins RG (2007) Antagonism of Platelet-Derived Growth Factor Receptor in Non–Small Cell Lung Cancer: Rationale and Investigations. Clin Cancer Res 13(15): 4632s–4636s. doi: 10.1158/1078-0432.CCR-07-0212 - DOI - PubMed
    1. Acunzo M., Visone R., Romano G. et al.. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 31, 634–642 (2012). doi: 10.1038/onc.2011.260 - DOI - PMC - PubMed

Publication types